当前位置: X-MOL 学术Morb. Mortal. Wkly. Rep. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022
Morbidity and Mortality Weekly Report ( IF 25.4 ) Pub Date : 2022-07-15 , DOI: 10.15585/mmwr.mm7129e1
Ruth Link-Gelles , Matthew E. Levy , Manjusha Gaglani , Stephanie A. Irving , Melissa Stockwell , Kristin Dascomb , Malini B. DeSilva , Sarah E. Reese , I-Chia Liao , Toan C. Ong , Shaun J. Grannis , Charlene McEvoy , Palak Patel , Nicola P. Klein , Emily Hartmann , Edward Stenehjem , Karthik Natarajan , Allison L. Naleway , Kempapura Murthy , Suchitra Rao , Brian E. Dixon , Anupam B. Kharbanda , Akintunde Akinseye , Monica Dickerson , Ned Lewis , Nancy Grisel , Jungmi Han , Michelle A. Barron , William F. Fadel , Margaret M. Dunne , Kristin Goddard , Julie Arndorfer , Deepika Konatham , Nimish R. Valvi , J. C. Currey , Bruce Fireman , Chandni Raiyani , Ousseny Zerbo , Chantel Sloan-Aagard , Sarah W. Ball , Mark G. Thompson , Mark W. Tenforde



中文翻译:


在 SARS-CoV-2 Omicron BA.1 和 BA.2/BA.2.12.1 亚系占主导地位期间,免疫功能正常的成年人中 2、3 和 4 剂 COVID-19 mRNA 疫苗的有效性 — VISION Network,10 个州,2021 年 12 月–2022 年 6 月


更新日期:2022-07-15
down
wechat
bug